SYK vs UTMD
SYK: A diversified medical technology leader offering surgical equipment, orthopedic robotics, and minimally invasive neurovascular products that collectively serve over 150 million patients annually across 61 countries. UTMD: Utah Medical Products designs and manufactures specialized medical devices focused on patient safety in critical care, neonatal intensive care, and women's health.
Side-by-side fundamentals
| Metric | SYK | UTMD | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $309.24 | $69.19 | |
| Market cap as of 2026-07-23 | $119.6B | $220M | |
| P/E as of 2026-07-23 | 35.83 | 20.29 | UTMD lower |
| PEG as of 2026-07-23 | 3.29 | n/a | |
| Net margin as of 2026-07-23 | +13.2% | +28.9% | UTMD higher |
| Gross margin as of 2026-07-23 | +64.2% | +57.9% | SYK higher |
| Operating margin as of 2026-07-23 | +19.7% | +28.8% | UTMD higher |
| ROE as of 2026-07-23 | +15.1% | +9.1% | SYK higher |
| ROA as of 2026-07-23 | +7.1% | +8.9% | UTMD higher |
| Debt / equity as of 2026-07-23 | 0.64 | 0.00 | UTMD lower |
| Revenue growth (YoY) as of 2026-07-23 | +8.8% | -4.4% | SYK higher |
| Revenue CAGR (3y) SEC XBRL | +10.8% | -9.7% | SYK higher |
| Dividend yield as of 2026-07-23 | +1.1% | +1.8% | UTMD higher |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-23 | 0.78 | 0.36 | |
| 1-year return as of 2026-07-22 close | -21.7% | +22.6% | UTMD higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.